205 related articles for article (PubMed ID: 35718282)
21. Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.
Shields AM; Faustini SE; Hill HJ; Al-Taei S; Tanner C; Ashford F; Workman S; Moreira F; Verma N; Wagg H; Heritage G; Campton N; Stamataki Z; Drayson MT; Klenerman P; Thaventhiran JED; Elkhalifa S; Goddard S; Johnston S; Huissoon A; Bethune C; Elcombe S; Lowe DM; Patel SY; Savic S; Richter AG; Burns SO;
Front Immunol; 2022; 13():912571. PubMed ID: 35720400
[TBL] [Abstract][Full Text] [Related]
22. Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults.
Zhang Y; Yang Y; Qiao N; Wang X; Ding L; Zhu X; Liang Y; Han Z; Liu F; Zhang X; Yang X
Front Med; 2022 Feb; 16(1):93-101. PubMed ID: 35122211
[TBL] [Abstract][Full Text] [Related]
23. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.
Farroni C; Picchianti-Diamanti A; Aiello A; Nicastri E; Laganà B; Agrati C; Castilletti C; Meschi S; Colavita F; Cuzzi G; Casetti R; Grassi G; Petrone L; Vanini V; Salmi A; Repele F; Altera AMG; Maffongelli G; Corpolongo A; Salemi S; Di Rosa R; Nalli G; Sesti G; Vaia F; Puro V; Goletti D
Front Immunol; 2022; 13():846753. PubMed ID: 35309297
[TBL] [Abstract][Full Text] [Related]
25. Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
Riise J; Meyer S; Blaas I; Chopra A; Tran TT; Delic-Sarac M; Hestdalen ML; Brodin E; Rustad EH; Dai KZ; Vaage JT; Nissen-Meyer LSH; Sund F; Wader KF; Bjornevik AT; Meyer PA; Nygaard GO; König M; Smeland S; Lund-Johansen F; Olweus J; Kolstad A
Br J Haematol; 2022 Jun; 197(6):697-708. PubMed ID: 35254660
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of side effects associated with COVID-19 vaccines in patients with inborn errors of immunity.
Özdemiral C; Cevik NN; Yavuz G; Gormez O; Zengin AB; Esenboga S; Karabulut E; Cagdas D
Clin Immunol; 2024 Feb; 259():109878. PubMed ID: 38122840
[TBL] [Abstract][Full Text] [Related]
27. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
Front Immunol; 2021; 12():726960. PubMed ID: 34671348
[TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
Wang J; Hou Z; Liu J; Gu Y; Wu Y; Chen Z; Ji J; Diao S; Qiu Y; Zou S; Zhang A; Zhang N; Wang F; Li X; Wang Y; Liu X; Lv C; Chen S; Liu D; Ji X; Liu C; Ren T; Sun J; Zhao Z; Wu F; Li F; Wang R; Yan Y; Zhang S; Ge G; Shao J; Yang S; Liu C; Huang Y; Xu D; Li X; Ai J; He Q; Zheng MH; Zhang L; Xie Q; Rockey DC; Fallowfield JA; Zhang W; Qi X
J Hepatol; 2021 Aug; 75(2):439-441. PubMed ID: 33905793
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults.
Ahn JY; Lee J; Suh YS; Song YG; Choi YJ; Lee KH; Seo SH; Song M; Oh JW; Kim M; Seo HY; Kwak JE; Youn JW; Woo JW; Shin EC; Sung YC; Park SH; Choi JY
Lancet Microbe; 2022 Mar; 3(3):e173-e183. PubMed ID: 35156068
[TBL] [Abstract][Full Text] [Related]
30. Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases.
Li H; Wang Y; Ao L; Ke M; Chen Z; Chen M; Peng M; Ling N; Hu P; Cai D; Zhang D; Ren H
Front Immunol; 2022; 13():988004. PubMed ID: 36275639
[TBL] [Abstract][Full Text] [Related]
31. Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19.
Ameratunga R; Longhurst H; Steele R; Lehnert K; Leung E; Brooks AES; Woon ST
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3575-3583. PubMed ID: 34182162
[TBL] [Abstract][Full Text] [Related]
32. Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study.
Zeng H; Liu H; Liu Z; Zhou X; Lu X; Yan Z; Zhou Y; Dai L; Chen Y; Yang T; Yin Z; Ye Z
Hum Vaccin Immunother; 2022 Nov; 18(5):2090176. PubMed ID: 35878733
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
Jin P; Guo X; Chen W; Ma S; Pan H; Dai L; Du P; Wang L; Jin L; Chen Y; Shi F; Liu J; Xu X; Zhang Y; Gao GF; Chen C; Feng J; Li J; Zhu F
PLoS Med; 2022 May; 19(5):e1003953. PubMed ID: 35617368
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy.
Syversen SW; Jyssum I; Tveter AT; Tran TT; Sexton J; Provan SA; Mjaaland S; Warren DJ; Kvien TK; Grødeland G; Nissen-Meyer LSH; Ricanek P; Chopra A; Andersson AM; Kro GB; Jahnsen J; Munthe LA; Haavardsholm EA; Vaage JT; Lund-Johansen F; Jørgensen KK; Goll GL
Arthritis Rheumatol; 2022 Aug; 74(8):1321-1332. PubMed ID: 35507355
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study.
Milota T; Sobotkova M; Smetanova J; Bloomfield M; Vydlakova J; Chovancova Z; Litzman J; Hakl R; Novak J; Malkusova I; Hanzlikova J; Jilek D; Hutyrova B; Novak V; Krcmova I; Sediva A; Kralickova P
Front Immunol; 2022; 13():835770. PubMed ID: 35296097
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review.
Lv J; Wu H; Xu J; Liu J
Infect Dis Poverty; 2022 May; 11(1):53. PubMed ID: 35562753
[TBL] [Abstract][Full Text] [Related]
37. SARS-COV-2 infections in inborn errors of immunity: A single center study.
Cousins K; DeFelice N; Jeong S; Feng J; Lee ASE; Rotella K; Sanchez D; Jaber F; Agarwal S; Ho HE; Cunningham-Rundles C
Front Immunol; 2022; 13():1035571. PubMed ID: 36479106
[TBL] [Abstract][Full Text] [Related]
38. Vaccination for SARS-CoV-2 in Hematological Patients.
Riccardi N; Falcone M; Yahav D
Acta Haematol; 2022; 145(3):257-266. PubMed ID: 35220303
[TBL] [Abstract][Full Text] [Related]
39. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study.
Meyts I; Bucciol G; Quinti I; Neven B; Fischer A; Seoane E; Lopez-Granados E; Gianelli C; Robles-Marhuenda A; Jeandel PY; Paillard C; Sankaran VG; Demirdag YY; Lougaris V; Aiuti A; Plebani A; Milito C; Dalm VA; Guevara-Hoyer K; Sánchez-Ramón S; Bezrodnik L; Barzaghi F; Gonzalez-Granado LI; Hayman GR; Uzel G; Mendonça LO; Agostini C; Spadaro G; Badolato R; Soresina A; Vermeulen F; Bosteels C; Lambrecht BN; Keller M; Mustillo PJ; Abraham RS; Gupta S; Ozen A; Karakoc-Aydiner E; Baris S; Freeman AF; Yamazaki-Nakashimada M; Scheffler-Mendoza S; Espinosa-Padilla S; Gennery AR; Jolles S; Espinosa Y; Poli MC; Fieschi C; Hauck F; Cunningham-Rundles C; Mahlaoui N; ; Warnatz K; Sullivan KE; Tangye SG
J Allergy Clin Immunol; 2021 Feb; 147(2):520-531. PubMed ID: 32980424
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 vaccination in cancer patients: a narrative review.
Seneviratne SL; Yasawardene P; Wijerathne W; Somawardana B
J Int Med Res; 2022 Mar; 50(3):3000605221086155. PubMed ID: 35313761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
